HTML Microdata document

This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
rdfs	http://www.w3.org/2000/01/rdf-schema#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
owl	http://www.w3.org/2002/07/owl#
nci	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdh	http://www.w3.org/2001/XMLSchema#

Statements

Subject Item: nci:C9760
rdf:type: owl:Class
rdfs:label: R-CHOP Regimen
rdfs:subClassOf: _:vb709412 _:vb709413 _:vb709414 _:vb709415 nci:C63442 _:vb709411 _:vb709416 _:vb709417
nci:P106: Therapeutic or Preventive Procedure
nci:P108: R-CHOP Regimen
nci:P207: C0393023
nci:P325: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma and mantle cell lymphoma and is being studied in the treatment of other types of cancer. It includes the drugs rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone.</n0:def-definition><n0:def-source>NCI-GLOSS</n0:def-source></n0:ComplexDefinition>
nci:P329: 632130
nci:P330: 632130
nci:P366: Rituximab_Cyclophosphamide_Doxorubicin_Prednisone_Vincristine
nci:P90: <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CTX/DOX/MOAB IDEC-C2B8/PRED/VCR</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Rituximab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>R-CHOP Regimen</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Rituxan/CHOP</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>R-CHOP regimen</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000635897</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>R-CHOP</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000635896</n0:source-code></n0:ComplexTerm>
nci:P97: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>An immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code: C9760

Subject Item: _:vb709411
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C933

Subject Item: _:vb709412
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C770

Subject Item: _:vb709413
rdf:type: owl:Restriction
owl:onProperty: nci:R172
owl:someValuesFrom: nci:C4337

Subject Item: _:vb709414
rdf:type: owl:Restriction
owl:onProperty: nci:R172
owl:someValuesFrom: nci:C3211

Subject Item: _:vb709415
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C405

Subject Item: _:vb709416
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C456

Subject Item: _:vb709417
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C1702